Cetera Advisor Networks’s abrdn Life Sciences Investors HQL Stock Holding History

Cetera Advisor Networks’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,467	Closed	-$259K	–	2121
2021 Q4	$259K	Buy	+13,467	New	+$271K	﹤0.01%	1703
2020 Q3	–	Sell	-4,775	Closed	-$86K	–	2007
2020 Q2	$86K	Buy	+4,775	New	+$81.9K	﹤0.01%	1602

Other funds holding HQL

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AUB

Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Cetera Advisor Networks's HQL Position: Q1 2022 in Review

Cetera Advisor Networks sold out of abrdn Life Sciences Investors (HQL) in Q1 2022, closing a stake of 13,467 shares — an estimated $259K sold.

Cetera Advisor Networks first reported a position in HQL in Q2 2020 and held it in 2 quarters. The position peaked at $259K in Q4 2021. 66 funds tracked by Wall St. Rank hold HQL as of Q1 2022.

Cetera Advisor Networks reported no remaining abrdn Life Sciences Investors position as of Q1 2022 after selling out during the quarter.
Cetera Advisor Networks sold 13,467 abrdn Life Sciences Investors shares in Q1 2022, an estimated $259K.
Cetera Advisor Networks first reported a position in abrdn Life Sciences Investors in Q2 2020 and held it in 2 quarters.
Cetera Advisor Networks's abrdn Life Sciences Investors position peaked at $259K in Q4 2021.
66 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2022.

Based on Cetera Advisor Networks's 13F filing for Q1 2022, filed 12 May 2022.